REPL
Replimune Group Inc
NASDAQ: REPL · HEALTHCARE · BIOTECHNOLOGY
$2.38
-7.39% today
Updated 2026-04-29
Market cap
$212.21M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-3.44
Dividend yield
—
52W range
$2 – $13
Volume
5.4M
Replimune Group Inc (REPL) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-90.90%
ROA
-43.20%
Debt/equity
0.37x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2017 | $0.00 | $-7.70M | — | — | — |
| 2018 | $0.00 | $-19.70M | — | — | — |
| 2019 | $0.00 | $-30.83M | — | — | — |
| 2020 | $0.00 | $-52.63M | — | — | — |
| 2021 | $0.00 | $-80.87M | — | — | — |
| 2022 | $0.00 | $-118.04M | — | — | — |
| 2023 | $0.00 | $-174.28M | — | — | — |
| 2024 | $0.00 | $-215.79M | — | — | — |
| 2025 | $0.00 | $-247.30M | — | — | — |